Phreesia Shares Surge 5.1% Driven by Investor Optimism
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 20 2026
0mins
Source: NASDAQ.COM
- Significant Price Increase: Phreesia's stock surged 5.1% in the last trading session to close at $11.77, with trading volume significantly exceeding normal levels, indicating heightened market confidence in its future performance.
- Investor Confidence Boost: Pale Fire Capital SE purchased 1,602,505 shares of Phreesia between March 17 and 19 for approximately $18.3 million, increasing its total holdings to 7,648,829 shares, which further bolstered market optimism about the company.
- Strong Earnings Expectations: Phreesia is expected to report quarterly earnings of $0.09 per share, reflecting a year-over-year increase of 181.8%, with revenues projected at $126.37 million, up 15.2% from the previous year, showcasing the company's growth potential.
- Market Focus: Although the consensus EPS estimate has remained unchanged over the past 30 days, research indicates a strong correlation between earnings estimate revisions and stock price movements, prompting investors to closely monitor Phreesia's future performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PHR
Wall Street analysts forecast PHR stock price to rise
12 Analyst Rating
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 9.540
Low
24.00
Averages
29.09
High
35.00
Current: 9.540
Low
24.00
Averages
29.09
High
35.00
About PHR
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Phreesia Class Action Lawsuit Notice
- Class Action Deadline: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, that they must apply to be lead plaintiff by July 13, 2026, or risk losing their right to compensation.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, leading to investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, highlighting its extensive experience and success in handling such cases.
- Investor Action Advice: Investors can visit Rosen Law Firm's website or call toll-free at 866-767-3653 for more information, and are advised to select qualified counsel with a proven track record to ensure their rights are effectively represented in the class action.
See More
Phreesia Faces Class Action Lawsuit Over Securities Violations
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Phreesia, aiming to recover damages for investors who purchased securities between May 8, 2025, and March 30, 2026, highlighting significant investor concerns regarding the company's future prospects.
- Allegations: The complaint alleges that Phreesia failed to disclose slowing demand and diminished visibility into key revenue streams during the class period, which undermined investor confidence in the company's operations and could negatively impact its stock performance.
- Market Impact: Due to the lawsuit's implications, Phreesia shareholders may face potential financial losses, and investors are encouraged to apply to be lead plaintiffs by July 13, 2026, to secure a share in any future recovery.
- Legal Fee Structure: Bronstein, Gewirtz & Grossman, LLC states they will represent investors on a contingency fee basis, meaning they will only charge fees if successful in recovering damages, thereby reducing financial risk for investors and encouraging more affected parties to join the lawsuit.
See More
Phreesia Faces Class Action Lawsuit Reminder for Investors
- Class Action Notice: The Schall Law Firm reminds investors of a class action lawsuit against Phreesia for violations of securities laws, concerning securities purchases made between May 8, 2025, and March 30, 2026, with a deadline to contact the firm by July 13, 2026.
- False Statements Allegation: The lawsuit alleges that Phreesia made false and misleading statements regarding its long-term growth outlook, misleading investors about its revenue targets despite existing uncertainties that could jeopardize its projections.
- Loss Recovery Opportunity: Investors are encouraged to join the lawsuit to recover losses, with the Schall Law Firm specializing in securities class actions and offering free consultations to help affected shareholders understand their rights.
- Lawsuit Status: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who take no action will be considered absent class members, potentially losing their chance to claim damages.
See More
Phreesia Stock Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Phreesia (NYSE:PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to participate in the class action and seek compensation.
- Fee Arrangement: Investors joining the class action will incur no out-of-pocket expenses, as the law firm operates on a contingency fee basis, minimizing the financial burden on investors.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first in 2017 for the number of securities class action settlements, demonstrating its expertise and success in this field.
See More
Guide to Lead Plaintiff Selection in Phreesia Securities Action
- Significant Stock Drop: Phreesia's shares plummeted by 27% on March 30, 2026, following a revenue outlook cut for fiscal 2027 from $545-$559 million to $510-$520 million, resulting in a loss of $3.03 per share, indicating a severe lack of market confidence in the company's growth prospects.
- Lead Plaintiff Deadline: Investors must file a motion by July 13, 2026, to seek appointment as lead plaintiff, with the court selecting based on the financial interest and ability to adequately represent the class, ensuring fair representation for all investors.
- Litigation Process Overview: After the deadline, the court will review all motions and appoint a lead plaintiff, followed by the filing of a consolidated complaint, leading the case through discovery and potentially to trial or settlement, which could significantly impact investor recoveries.
- Rights of Absent Class Members: Investors who purchased PHR securities during the class period but do not seek lead plaintiff status retain their rights to any future recovery and will be notified of any proposed settlements, ensuring their ability to participate in potential compensation processes.
See More
Phreesia Class Action Reminder for Investors
- Class Action Notice: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked first in 2017 for the number of securities class action settlements, demonstrating its expertise and success in this field.
- How to Participate: Investors can visit the Rosen Law Firm website or call toll-free at 866-767-3653 for more information, ensuring they select qualified legal counsel to protect their rights and avoid inexperienced intermediary firms.
See More
Phreesia Class Action Lawsuit Notice
- Class Action Deadline: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, that they must apply to be lead plaintiff by July 13, 2026, or risk losing their right to compensation.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, leading to investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, highlighting its extensive experience and success in handling such cases.
- Investor Action Advice: Investors can visit Rosen Law Firm's website or call toll-free at 866-767-3653 for more information, and are advised to select qualified counsel with a proven track record to ensure their rights are effectively represented in the class action.
See More
Phreesia Faces Class Action Lawsuit Over Securities Violations
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Phreesia, aiming to recover damages for investors who purchased securities between May 8, 2025, and March 30, 2026, highlighting significant investor concerns regarding the company's future prospects.
- Allegations: The complaint alleges that Phreesia failed to disclose slowing demand and diminished visibility into key revenue streams during the class period, which undermined investor confidence in the company's operations and could negatively impact its stock performance.
- Market Impact: Due to the lawsuit's implications, Phreesia shareholders may face potential financial losses, and investors are encouraged to apply to be lead plaintiffs by July 13, 2026, to secure a share in any future recovery.
- Legal Fee Structure: Bronstein, Gewirtz & Grossman, LLC states they will represent investors on a contingency fee basis, meaning they will only charge fees if successful in recovering damages, thereby reducing financial risk for investors and encouraging more affected parties to join the lawsuit.
See More
Phreesia Faces Class Action Lawsuit Reminder for Investors
- Class Action Notice: The Schall Law Firm reminds investors of a class action lawsuit against Phreesia for violations of securities laws, concerning securities purchases made between May 8, 2025, and March 30, 2026, with a deadline to contact the firm by July 13, 2026.
- False Statements Allegation: The lawsuit alleges that Phreesia made false and misleading statements regarding its long-term growth outlook, misleading investors about its revenue targets despite existing uncertainties that could jeopardize its projections.
- Loss Recovery Opportunity: Investors are encouraged to join the lawsuit to recover losses, with the Schall Law Firm specializing in securities class actions and offering free consultations to help affected shareholders understand their rights.
- Lawsuit Status: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who take no action will be considered absent class members, potentially losing their chance to claim damages.
See More
Phreesia Stock Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Phreesia (NYSE:PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to participate in the class action and seek compensation.
- Fee Arrangement: Investors joining the class action will incur no out-of-pocket expenses, as the law firm operates on a contingency fee basis, minimizing the financial burden on investors.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first in 2017 for the number of securities class action settlements, demonstrating its expertise and success in this field.
See More
Guide to Lead Plaintiff Selection in Phreesia Securities Action
- Significant Stock Drop: Phreesia's shares plummeted by 27% on March 30, 2026, following a revenue outlook cut for fiscal 2027 from $545-$559 million to $510-$520 million, resulting in a loss of $3.03 per share, indicating a severe lack of market confidence in the company's growth prospects.
- Lead Plaintiff Deadline: Investors must file a motion by July 13, 2026, to seek appointment as lead plaintiff, with the court selecting based on the financial interest and ability to adequately represent the class, ensuring fair representation for all investors.
- Litigation Process Overview: After the deadline, the court will review all motions and appoint a lead plaintiff, followed by the filing of a consolidated complaint, leading the case through discovery and potentially to trial or settlement, which could significantly impact investor recoveries.
- Rights of Absent Class Members: Investors who purchased PHR securities during the class period but do not seek lead plaintiff status retain their rights to any future recovery and will be notified of any proposed settlements, ensuring their ability to participate in potential compensation processes.
See More
Phreesia Class Action Reminder for Investors
- Class Action Notice: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked first in 2017 for the number of securities class action settlements, demonstrating its expertise and success in this field.
- How to Participate: Investors can visit the Rosen Law Firm website or call toll-free at 866-767-3653 for more information, ensuring they select qualified legal counsel to protect their rights and avoid inexperienced intermediary firms.
See More
